Schema therapy for long-lasting, hard-to-treat depression
Part of Mental health clinical trials.
This study tests whether schema therapy can help people with chronic depression that hasn’t improved enough with standard antidepressant treatments. You’d be in a psychiatric clinic and be assessed for severity and diagnosis, then receive the therapy being studied.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re being referred for depression as your main (primary) problem in a psychiatric clinic
- Your depression has lasted at least 2 years OR hasn’t improved after at least two different antidepressant trials taken long enough and in adequate doses
- Your depression severity is at least moderate to severe on a depression symptom scale (HAMD-6 score of 9 or higher)
- You do not have alcohol or substance abuse problems
- You do not have bipolar disorder or a psychotic disorder
- You are not pregnant at the time you join, and you can speak Danish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a psilocybin-based treatment can help people with depression that has not improved after trying several antidepressants. You will receive the study treatment and have brain scans to see how it affects brain connections.
This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.
This study tests whether a combination of psilocybin (a psychedelic substance) and transcranial magnetic stimulation (rTMS, a noninvasive brain stimulation) can help people with treatment-resistant depression. It involves daily visits to the research center for about 2 weeks.
This study compares two psychotherapy programs to help people who have ongoing, difficult-to-treat depression while in inpatient care. If you qualify, you’ll receive one of the therapy programs and be followed to see which approach helps depression symptoms more.
This study looks at how the brain's frontal lobe (DLPFC) works during memory tasks in people with treatment-resistant depression. It compares brain activity between depressed patients and healthy controls using MRI and possibly a brain stimulation technique (rTMS). It aims to understand why some people don't respond to standard treatments.
This trial tests whether deep brain stimulation (DBS) — a surgical treatment that uses tiny electrical pulses to change brain activity — can help people with severe, long-lasting depression that hasn't responded to other treatments.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.